HEADER ONCOPROTEIN 05-OCT-21 7PVU TITLE CRYSTAL STRUCTURE OF P38ALPHA C162S IN COMPLEX WITH CAS2094511-69-8, P TITLE 2 1 21 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MAP KINASE 14,MAPK 14,CRK1,MITOGEN-ACTIVATED PROTEIN KINASE COMPND 5 P38 ALPHA,MAP KINASE P38 ALPHA; COMPND 6 EC: 2.7.11.24; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: MAPK14, CRK1, CSBP1, CSBP2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, ENZYME, INHIBITOR, LIGAND, ONCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR B.BAGINSKI,J.POUS,L.GONZALEZ,M.J.MACIAS,A.R.NEBREDA REVDAT 4 07-FEB-24 7PVU 1 REMARK REVDAT 3 21-JUN-23 7PVU 1 JRNL REVDAT 2 14-JUN-23 7PVU 1 JRNL REVDAT 1 17-MAY-23 7PVU 0 JRNL AUTH L.GONZALEZ,L.DIAZ,J.POUS,B.BAGINSKI,A.DURAN-CORBERA, JRNL AUTH 2 M.SCARPA,I.BRUN-HEATH,A.IGEA,P.MARTIN-MALPARTIDA,L.RUIZ, JRNL AUTH 3 C.PALLARA,M.ESGUERRA,F.COLIZZI,C.MAYOR-RUIZ,R.M.BIONDI, JRNL AUTH 4 R.SOLIVA,M.J.MACIAS,M.OROZCO,A.R.NEBREDA JRNL TITL CHARACTERIZATION OF P38 ALPHA AUTOPHOSPHORYLATION INHIBITORS JRNL TITL 2 THAT TARGET THE NON-CANONICAL ACTIVATION PATHWAY. JRNL REF NAT COMMUN V. 14 3318 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 37308482 JRNL DOI 10.1038/S41467-023-39051-X REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0405 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 79.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 38816 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.191 REMARK 3 FREE R VALUE TEST SET COUNT : 2015 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2561 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.90 REMARK 3 BIN R VALUE (WORKING SET) : 0.2620 REMARK 3 BIN FREE R VALUE SET COUNT : 155 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5433 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 186 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.18200 REMARK 3 B22 (A**2) : -1.30800 REMARK 3 B33 (A**2) : 1.42600 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.26300 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.283 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.206 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.163 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.974 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5566 ; 0.002 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 5321 ; 0.001 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7560 ; 0.934 ; 1.655 REMARK 3 BOND ANGLES OTHERS (DEGREES): 12242 ; 0.319 ; 1.580 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 666 ; 5.474 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 37 ; 3.117 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 965 ;12.907 ;10.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 845 ; 0.041 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6423 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1281 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1110 ; 0.189 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 59 ; 0.172 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2736 ; 0.172 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 174 ; 0.149 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2670 ; 1.642 ; 3.734 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2670 ; 1.642 ; 3.734 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3328 ; 2.919 ; 6.700 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3329 ; 2.918 ; 6.701 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2896 ; 1.453 ; 3.920 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2897 ; 1.453 ; 3.921 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 4228 ; 2.593 ; 7.132 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4229 ; 2.593 ; 7.134 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 5 A 353 REMARK 3 ORIGIN FOR THE GROUP (A): 14.3334 37.8355 3.9162 REMARK 3 T TENSOR REMARK 3 T11: 0.0312 T22: 0.0404 REMARK 3 T33: 0.0453 T12: -0.0124 REMARK 3 T13: -0.0278 T23: -0.0154 REMARK 3 L TENSOR REMARK 3 L11: 0.8800 L22: 3.4310 REMARK 3 L33: 0.4972 L12: 0.7432 REMARK 3 L13: -0.2589 L23: -0.8942 REMARK 3 S TENSOR REMARK 3 S11: 0.0975 S12: -0.1440 S13: -0.0036 REMARK 3 S21: 0.2872 S22: -0.1260 S23: -0.2713 REMARK 3 S31: -0.0842 S32: 0.0988 S33: 0.0285 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 0 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 ORIGIN FOR THE GROUP (A): 16.2609 24.9584 46.1319 REMARK 3 T TENSOR REMARK 3 T11: 0.1249 T22: 0.3153 REMARK 3 T33: 0.0915 T12: -0.0254 REMARK 3 T13: 0.0402 T23: -0.0381 REMARK 3 L TENSOR REMARK 3 L11: 2.1792 L22: 2.7458 REMARK 3 L33: 2.1868 L12: 0.0403 REMARK 3 L13: 0.3103 L23: 1.5602 REMARK 3 S TENSOR REMARK 3 S11: 0.1980 S12: -0.1675 S13: -0.0926 REMARK 3 S21: 0.0514 S22: -0.1210 S23: 0.2125 REMARK 3 S31: 0.1551 S32: -0.1747 S33: -0.0770 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7PVU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1292118383. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-OCT-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979260 REMARK 200 MONOCHROMATOR : SI(111) CHANNEL-CUT, CRYOCOOLED REMARK 200 OPTICS : ELIPTICALLY BENT MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 7.3.0 REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.22 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44958 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820 REMARK 200 RESOLUTION RANGE LOW (A) : 79.702 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : 0.45300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: 3QUE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 27% PEG 3350, 0,1M BIS-TRIS PH 6.8, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.03600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 GLU A 4 REMARK 465 ALA A 172 REMARK 465 ARG A 173 REMARK 465 HIS A 174 REMARK 465 THR A 175 REMARK 465 ASP A 176 REMARK 465 ASP A 177 REMARK 465 GLU A 178 REMARK 465 MET A 179 REMARK 465 THR A 180 REMARK 465 GLY A 181 REMARK 465 TYR A 182 REMARK 465 VAL A 183 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLN B 3 REMARK 465 GLU B 4 REMARK 465 ARG B 173 REMARK 465 HIS B 174 REMARK 465 THR B 175 REMARK 465 ASP B 176 REMARK 465 ASP B 177 REMARK 465 GLU B 178 REMARK 465 MET B 179 REMARK 465 THR B 180 REMARK 465 GLY B 181 REMARK 465 TYR B 182 REMARK 465 VAL B 183 REMARK 465 ALA B 184 REMARK 465 THR B 185 REMARK 465 ASP B 354 REMARK 465 GLN B 355 REMARK 465 GLU B 356 REMARK 465 GLU B 357 REMARK 465 MET B 358 REMARK 465 GLU B 359 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ALA A 34 REMARK 475 TYR A 35 REMARK 475 LYS B 118 REMARK 475 CYS B 119 REMARK 475 GLN B 120 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 14 -117.01 64.54 REMARK 500 ASN A 100 -44.84 -137.98 REMARK 500 ARG A 149 -15.95 89.97 REMARK 500 ASP A 150 48.87 -142.42 REMARK 500 PHE A 274 69.10 -115.26 REMARK 500 PRO B 29 104.17 -51.80 REMARK 500 TYR B 35 78.92 55.24 REMARK 500 TYR B 35 80.52 53.34 REMARK 500 CYS B 119 -82.11 66.59 REMARK 500 ARG B 149 -39.67 86.90 REMARK 500 ASP B 168 91.10 51.46 REMARK 500 ASN B 196 61.09 62.27 REMARK 500 ASN B 201 -155.18 -151.39 REMARK 500 LEU B 289 65.31 -107.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 VAL B 117 -13.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 556 DISTANCE = 5.82 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7PV3 RELATED DB: PDB REMARK 900 SIMILAR LIGAND (WITHOUT THE FLUORIDE ATOM), IN THE CATALYTIC SITE, REMARK 900 PLUS AN INHIBITOR. REMARK 900 RELATED ID: 7Q1A RELATED DB: PDB REMARK 900 SIMILAR LIGAND (WITHOUT THE FLUORIDE ATOM), NEARBY CATALYTIC SITE, REMARK 900 PLUS AN INHIBITOR. DBREF 7PVU A 1 359 UNP P47811 MK14_MOUSE 1 359 DBREF 7PVU B 1 359 UNP P47811 MK14_MOUSE 1 359 SEQADV 7PVU SER A 162 UNP P47811 CYS 162 CONFLICT SEQADV 7PVU SER B 162 UNP P47811 CYS 162 CONFLICT SEQRES 1 A 359 MET SER GLN GLU ARG PRO THR PHE TYR ARG GLN GLU LEU SEQRES 2 A 359 ASN LYS THR ILE TRP GLU VAL PRO GLU ARG TYR GLN ASN SEQRES 3 A 359 LEU SER PRO VAL GLY SER GLY ALA TYR GLY SER VAL CYS SEQRES 4 A 359 ALA ALA PHE ASP THR LYS THR GLY HIS ARG VAL ALA VAL SEQRES 5 A 359 LYS LYS LEU SER ARG PRO PHE GLN SER ILE ILE HIS ALA SEQRES 6 A 359 LYS ARG THR TYR ARG GLU LEU ARG LEU LEU LYS HIS MET SEQRES 7 A 359 LYS HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL PHE THR SEQRES 8 A 359 PRO ALA ARG SER LEU GLU GLU PHE ASN ASP VAL TYR LEU SEQRES 9 A 359 VAL THR HIS LEU MET GLY ALA ASP LEU ASN ASN ILE VAL SEQRES 10 A 359 LYS CYS GLN LYS LEU THR ASP ASP HIS VAL GLN PHE LEU SEQRES 11 A 359 ILE TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER SEQRES 12 A 359 ALA ASP ILE ILE HIS ARG ASP LEU LYS PRO SER ASN LEU SEQRES 13 A 359 ALA VAL ASN GLU ASP SER GLU LEU LYS ILE LEU ASP PHE SEQRES 14 A 359 GLY LEU ALA ARG HIS THR ASP ASP GLU MET THR GLY TYR SEQRES 15 A 359 VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU SEQRES 16 A 359 ASN TRP MET HIS TYR ASN GLN THR VAL ASP ILE TRP SER SEQRES 17 A 359 VAL GLY CYS ILE MET ALA GLU LEU LEU THR GLY ARG THR SEQRES 18 A 359 LEU PHE PRO GLY THR ASP HIS ILE ASP GLN LEU LYS LEU SEQRES 19 A 359 ILE LEU ARG LEU VAL GLY THR PRO GLY ALA GLU LEU LEU SEQRES 20 A 359 LYS LYS ILE SER SER GLU SER ALA ARG ASN TYR ILE GLN SEQRES 21 A 359 SER LEU ALA GLN MET PRO LYS MET ASN PHE ALA ASN VAL SEQRES 22 A 359 PHE ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU LEU GLU SEQRES 23 A 359 LYS MET LEU VAL LEU ASP SER ASP LYS ARG ILE THR ALA SEQRES 24 A 359 ALA GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN TYR HIS SEQRES 25 A 359 ASP PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR ASP GLN SEQRES 26 A 359 SER PHE GLU SER ARG ASP LEU LEU ILE ASP GLU TRP LYS SEQRES 27 A 359 SER LEU THR TYR ASP GLU VAL ILE SER PHE VAL PRO PRO SEQRES 28 A 359 PRO LEU ASP GLN GLU GLU MET GLU SEQRES 1 B 359 MET SER GLN GLU ARG PRO THR PHE TYR ARG GLN GLU LEU SEQRES 2 B 359 ASN LYS THR ILE TRP GLU VAL PRO GLU ARG TYR GLN ASN SEQRES 3 B 359 LEU SER PRO VAL GLY SER GLY ALA TYR GLY SER VAL CYS SEQRES 4 B 359 ALA ALA PHE ASP THR LYS THR GLY HIS ARG VAL ALA VAL SEQRES 5 B 359 LYS LYS LEU SER ARG PRO PHE GLN SER ILE ILE HIS ALA SEQRES 6 B 359 LYS ARG THR TYR ARG GLU LEU ARG LEU LEU LYS HIS MET SEQRES 7 B 359 LYS HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL PHE THR SEQRES 8 B 359 PRO ALA ARG SER LEU GLU GLU PHE ASN ASP VAL TYR LEU SEQRES 9 B 359 VAL THR HIS LEU MET GLY ALA ASP LEU ASN ASN ILE VAL SEQRES 10 B 359 LYS CYS GLN LYS LEU THR ASP ASP HIS VAL GLN PHE LEU SEQRES 11 B 359 ILE TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER SEQRES 12 B 359 ALA ASP ILE ILE HIS ARG ASP LEU LYS PRO SER ASN LEU SEQRES 13 B 359 ALA VAL ASN GLU ASP SER GLU LEU LYS ILE LEU ASP PHE SEQRES 14 B 359 GLY LEU ALA ARG HIS THR ASP ASP GLU MET THR GLY TYR SEQRES 15 B 359 VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU SEQRES 16 B 359 ASN TRP MET HIS TYR ASN GLN THR VAL ASP ILE TRP SER SEQRES 17 B 359 VAL GLY CYS ILE MET ALA GLU LEU LEU THR GLY ARG THR SEQRES 18 B 359 LEU PHE PRO GLY THR ASP HIS ILE ASP GLN LEU LYS LEU SEQRES 19 B 359 ILE LEU ARG LEU VAL GLY THR PRO GLY ALA GLU LEU LEU SEQRES 20 B 359 LYS LYS ILE SER SER GLU SER ALA ARG ASN TYR ILE GLN SEQRES 21 B 359 SER LEU ALA GLN MET PRO LYS MET ASN PHE ALA ASN VAL SEQRES 22 B 359 PHE ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU LEU GLU SEQRES 23 B 359 LYS MET LEU VAL LEU ASP SER ASP LYS ARG ILE THR ALA SEQRES 24 B 359 ALA GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN TYR HIS SEQRES 25 B 359 ASP PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR ASP GLN SEQRES 26 B 359 SER PHE GLU SER ARG ASP LEU LEU ILE ASP GLU TRP LYS SEQRES 27 B 359 SER LEU THR TYR ASP GLU VAL ILE SER PHE VAL PRO PRO SEQRES 28 B 359 PRO LEU ASP GLN GLU GLU MET GLU HET 8DI B 401 24 HETNAM 8DI N-(2-CYCLOBUTYL-1H-1,3-BENZODIAZOL-5-YL)-2- HETNAM 2 8DI FLUOROBENZENE-1-SULFONAMIDE HETSYN 8DI N-(2-CYCLOBUTYL-1H-BENZIMIDAZOL-5-YL)-2-FLUORANYL- HETSYN 2 8DI BENZENESULFONAMIDE FORMUL 3 8DI C17 H16 F N3 O2 S FORMUL 4 HOH *186(H2 O) HELIX 1 AA1 SER A 61 MET A 78 1 18 HELIX 2 AA2 ASP A 112 VAL A 117 1 6 HELIX 3 AA3 THR A 123 SER A 143 1 21 HELIX 4 AA4 LYS A 152 SER A 154 5 3 HELIX 5 AA5 ALA A 190 LEU A 195 1 6 HELIX 6 AA6 THR A 203 GLY A 219 1 17 HELIX 7 AA7 ASP A 227 GLY A 240 1 14 HELIX 8 AA8 GLY A 243 LYS A 248 1 6 HELIX 9 AA9 SER A 252 LEU A 262 1 11 HELIX 10 AB1 ASN A 269 PHE A 274 1 6 HELIX 11 AB2 ASN A 278 LEU A 289 1 12 HELIX 12 AB3 THR A 298 ALA A 304 1 7 HELIX 13 AB4 HIS A 305 ALA A 309 5 5 HELIX 14 AB5 ASP A 313 GLU A 317 5 5 HELIX 15 AB6 GLN A 325 ARG A 330 5 6 HELIX 16 AB7 LEU A 333 SER A 347 1 15 HELIX 17 AB8 SER B 61 MET B 78 1 18 HELIX 18 AB9 SER B 95 PHE B 99 5 5 HELIX 19 AC1 LEU B 113 VAL B 117 1 5 HELIX 20 AC2 THR B 123 SER B 143 1 21 HELIX 21 AC3 LYS B 152 SER B 154 5 3 HELIX 22 AC4 ALA B 190 LEU B 195 1 6 HELIX 23 AC5 THR B 203 GLY B 219 1 17 HELIX 24 AC6 ASP B 227 GLY B 240 1 14 HELIX 25 AC7 GLY B 243 LYS B 248 1 6 HELIX 26 AC8 SER B 252 LEU B 262 1 11 HELIX 27 AC9 ASN B 269 PHE B 274 1 6 HELIX 28 AD1 ASN B 278 LEU B 289 1 12 HELIX 29 AD2 THR B 298 ALA B 304 1 7 HELIX 30 AD3 HIS B 305 ALA B 309 5 5 HELIX 31 AD4 ASP B 313 GLU B 317 5 5 HELIX 32 AD5 GLN B 325 ARG B 330 5 6 HELIX 33 AD6 LEU B 333 PHE B 348 1 16 SHEET 1 AA1 2 PHE A 8 LEU A 13 0 SHEET 2 AA1 2 THR A 16 PRO A 21 -1 O TRP A 18 N GLN A 11 SHEET 1 AA2 5 TYR A 24 SER A 32 0 SHEET 2 AA2 5 GLY A 36 ASP A 43 -1 O VAL A 38 N GLY A 31 SHEET 3 AA2 5 HIS A 48 LEU A 55 -1 O VAL A 52 N CYS A 39 SHEET 4 AA2 5 TYR A 103 HIS A 107 -1 O THR A 106 N ALA A 51 SHEET 5 AA2 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 AA3 2 LEU A 156 VAL A 158 0 SHEET 2 AA3 2 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 SHEET 1 AA4 2 PHE B 8 LEU B 13 0 SHEET 2 AA4 2 THR B 16 PRO B 21 -1 O TRP B 18 N GLN B 11 SHEET 1 AA5 5 TYR B 24 GLY B 31 0 SHEET 2 AA5 5 SER B 37 ASP B 43 -1 O PHE B 42 N GLN B 25 SHEET 3 AA5 5 ARG B 49 LYS B 54 -1 O VAL B 50 N ALA B 41 SHEET 4 AA5 5 TYR B 103 HIS B 107 -1 O LEU B 104 N LYS B 53 SHEET 5 AA5 5 ASP B 88 PHE B 90 -1 N ASP B 88 O VAL B 105 SHEET 1 AA6 3 ALA B 111 ASP B 112 0 SHEET 2 AA6 3 LEU B 156 VAL B 158 -1 O VAL B 158 N ALA B 111 SHEET 3 AA6 3 LEU B 164 ILE B 166 -1 O LYS B 165 N ALA B 157 CRYST1 67.141 68.072 79.980 90.00 94.78 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014894 0.000000 0.001245 0.00000 SCALE2 0.000000 0.014690 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012547 0.00000